Treatment of experimental murine pancreatic peritoneal carcinomatosis with fibroblasts genetically modified to express IL12: a role for peritoneal innate immunity. [electronic resource]
Producer: 20070201Description: 107-14 p. digitalISSN:- 0017-5749
- Animals
- Antineoplastic Agents -- immunology
- Cell Division -- immunology
- Cell Line, Tumor
- Disease Models, Animal
- Female
- Fibroblasts -- immunology
- Flow Cytometry -- methods
- Genetic Therapy -- methods
- Immunity, Innate -- immunology
- Immunohistochemistry -- methods
- Injections, Intraperitoneal
- Interleukin-12 -- administration & dosage
- Macrophages -- immunology
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Nitric Oxide -- biosynthesis
- Pancreatic Neoplasms -- genetics
- Peritoneal Neoplasms -- genetics
- Reactive Oxygen Species -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.